Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation

BACKGROUND: There is limited information on treatment strategies and monitoring strategies for late antibody-mediated rejection (ABMR) after kidney transplantation. METHODS: In this observational and nonrandomized study, we compared 78 patients diagnosed with late ABMR (>3 months after transplant...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transplant Direct
Main Authors: Parajuli, Sandesh, Mandelbrot, Didier A., Muth, Brenda, Mohamed, Maha, Garg, Neetika, Aziz, Fahad, Redfield, Robert R., Zhong, Weixiong, Astor, Brad C., Djamali, Arjang
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2017
Teme:
Kidney Transplantation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828696/
https://ncbi.nlm.nih.gov/pubmed/29536028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000746
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki